About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Kalytera Announces Completion of Food Effect and QTc Study
July 16, 2019
Kalytera to Hold Annual and Special Meeting on July 29, 2019
July 5, 2019
Kalytera to Acquire CBD Extraction Business
June 27, 2019
Kalytera Provides Update on GVHD Program
June 25, 2019
Kalytera Announces Grant of Stock Options to Directors
June 21, 2019
Kalytera Announces Changes to Board of Directors
June 21, 2019
Kalytera Announces Additional Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
June 18, 2019
View all News and Insights
Browse by Year
2019
2018
2017
2016
2015
